COMPARISON OF BREATHING AND SUBOCCIPITAL RELEASE IN STROKE (NCT07725471) | Clinical Trial Compass
RecruitingNot Applicable
COMPARISON OF BREATHING AND SUBOCCIPITAL RELEASE IN STROKE
Turkey (Türkiye)54 participantsStarted 2026-07-06
Plain-language summary
The aim of this study is to investigate the positive effects of deep, slow breathing exercises and suboccipital relaxation, when added to a routine physiotherapy and rehabilitation program, on autonomic, motor, cognitive, and emotional status functions in individuals who have experienced a stroke, and to examine their superiority compared to routine physiotherapy and rehabilitation alone.
Who can participate
Age range
18 Years – 84 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* First-time diagnosis of stroke
* Presence of unilateral hemiplegia due to ischemic or hemorrhagic stroke etiology
* Presence of hemiparesis
* At least 3 months post-stroke
* Having signed the informed consent form
* Aged between 18 and 84 years
Exclusion Criteria:
* Presence of active or chronic respiratory disease
* Low heart rate (\<60 bpm)
* Known cardiac conduction disorder
* Symptomatic carotid or vertebrobasilar stenosis
* Severe carotid or vertebrobasilar stenosis
* Advanced liver, kidney, heart, or lung disease
* Diagnosed depression
* Pregnancy
* Severe aphasia or cognitive impairment that may interfere with the informed consent process or study procedures
* Malignant tumors or infectious diseases
* Presence of a pacemaker or other implanted electrical device
* Spasticity of grade 4 or higher according to the Modified Ashworth Scale in the upper and lower extremities
* Brunnstrom Motor Staging below stage 3 in the upper and lower extremities
* Failure to meet the inclusion criteria
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Heart Rate Variability (HRV)
Timeframe: Baseline and after 6 weeks of intervention